BrightInsight CEO Kal Patel M.D. discusses the future of regulated digital health for biopharma and medtech [Sponsored] January 4, 2022 Auto Bot BioPharma, BrightInsight, Health IT, Health Services, Health Tech, Medical Devices, MedTech, News, Policy, Sponsored Post, virtual health 0 In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.